TBAT Innovation Ltd’s Post

Exciting news The Global Life Sciences Board of Research (GLSBOR) has partnered with the UN and EU to launch a new grant program for medical conferences. This initiative aims to enhance healthcare practices globally. Conference organizers in UN and EU member states, don't miss this opportunity! Learn more at GLSBOR's website. #HealthcareInnovation #MedicalConferences #GlobalHealth #GLSBOR #UnitedNations #EuropeanUnion 2. Attention medical conference organizers! GLSBOR, in collaboration with the UN and EU, is offering grants to support conferences focused on enhancing healthcare practices. If your event aims to improve patient care, integrate new technologies, or foster international collaboration, apply now! Details at GLSBOR.org #MedicalGrants #HealthcarePractice #GlobalCollaboration #GLSBOR #UNInitiative #EUHealthcare 3. Calling all healthcare innovators! The Global Life Sciences Board of Research has announced a groundbreaking grant program for medical conferences. In partnership with the UN and EU, this initiative seeks to accelerate improvements in global healthcare delivery. Interested? Contact [email protected] for more information. #HealthcareEnhancement #MedicalInnovation #GlobalHealthGrants #GLSBOR #UNProjects https://lnkd.in/enqD6amr

Discover how to elevate your research with meaningful #patientengagement! In this virtual workshop, UHN’s Pride in Patient Engagement (PiPER) team will highlight essential tools and insights from the PiPER toolkit to help researchers effectively plan, implement, and evaluate patient engagement in research (PER). Effective PER can positively influence the quality of research and the ability to create successful grant applications. During the workshop, participants will learn about: ◼ Concepts related to PER ◼ The roles people with lived experience can play in research ◼ Training resources specific to the roles that individuals can play within research projects, programs, departments, or research institutes at UHN ◼ Tools to plan, implement, and evaluate the success of PER ◼ Overview of PER related to grant applications The workshop is designed for UHN scientists, research staff, trainees, community organizations, as well as current and future patients and care partners. The workshop is free and open to everyone. Workshop recording will be sent to all registrants. Register now here: https://lnkd.in/eeMsyEJE

🚀 DPHS Approaching Five: Not Just New Kids Anymore As we approach our fifth year in clinical research, it might seem like we're still at the kiddie table. But at DPHS, we’ve been doing some serious growing up. We’re not just the new kids on the block—we’re the fast learners, the early adopters, the innovators who are trying to make waves. 🌟 Our Journey So Far In nearly five years, we’ve moved from being a hopeful startup to a vigorous force within the clinical research industry. We've been building robust systems and embracing cutting-edge technology, cultivating a team that’s passionate about transforming healthcare through research. 🔍 Experience vs. Fresh Perspective While we respect the wisdom that decades in the field can bring, we also believe that fresh perspectives are crucial for innovation. DPHS blends the vigor of a young company with the wisdom gained from our rapid growth and diverse experiences. Proving Our Mettle: We’ve tackled complex trials, navigated regulatory landscapes, and delivered results that speak louder than our age might suggest. Agility and Adaptability: Being younger in the industry means we can pivot and adapt quickly—an essential trait in the ever-evolving world of healthcare research. 🚀 New Tagline, New Vision As we continue to evolve, we're also refining how we present ourselves to the world. We're proud to unveil our new tagline: "Shifting Clinical Research Paradigm." This isn't just a change in wording—it's a commitment to continually challenge and advance the standards of clinical research. Our new tagline reflects our ambition to not just participate in but actively transform the field. 🤔 Looking Ahead As DPHS moves forward, we invite industry leaders, potential partners, and innovative minds to join us in rethinking what’s possible in clinical research. 🤝 Let’s Talk What challenges do you think younger companies like ours should be prepared to meet? How can we leverage our unique position for greater impact? Share your thoughts and let’s shape the future together. #DPHS #ClinicalResearch #Innovation #HealthcareGrowth #FutureOfHealthcare

The gap between research findings and clinical implementation poses a significant challenge in healthcare. Bridging this gap is essential to ensure that the latest evidence is incorporated into patient care effectively. In order to achieve this aim, on 10-11 October 2024, CCI4EU is delivering its first conference, which will focus on "Bridging research insights into clinical implementation". The conference will be a combination of lectures by international experts, discussions and breakout sessions aiming at:  > Understanding the importance of capacity building in research and innovation. > Learning how to develop a research programme. > Identifying the ways to bring research findings into clinical settings. > Enhancing collaboration between the Stakeholders and other research centres. > Exploring real-world case studies and examples of successful/unsuccessful and ongoing research. ❗ Application deadline: 30.06.2024 ➡️ To learn more: https://lnkd.in/dTCHmDN3 ➡️ Go to the CCI4EU website: https://cci4eu.eu/

Clinical Research 2024 Conference which is scheduled during August 08-09, 2024 at London, UK is just around the corner. This year, we're bringing together leading experts, researchers, and practitioners from around the world to discuss the latest advancements and trends in clinical research. #ClinicalResearch2024 #medicalinnovation #healthcareleaders #networking #healthcareprofessionals #Workshops #handsonlearning #medicaleducation

Our Chief Executive, Roland Sinker, who is also the National Director for Life Sciences at NHS England, has led the development of a new report that outlines how the NHS has unparalleled potential to become a world leader in healthcare innovation testing and adoption. Innovation is in the DNA of the NHS, and there is a clear sense that the UK could – and should – be the world’s test bed for healthcare innovation. Featured in the Financial Times, this report highlights how the UK’s £108.1 billion life sciences sector turnover and world-leading healthcare data present a unique opportunity to transform care delivery to meet patients’ needs now and in the future. By combining cutting-edge research, clinical expertise, and the scale of the NHS with the life sciences industry, the UK can deliver transformative benefits for patients and cement its status as a global leader. As part of the largest life sciences cluster in Europe here in Cambridge, we’re proud to work alongside one of the most productive communities of researchers in the world. This rich ecosystem of innovation and clinical expertise will change lives across the UK and beyond. Read the full report https://orlo.uk/iZEaC

#DIAEurope2025 is must have for pharmaceutical, drug development & clinical trials industry ✅️ In addition, this year the conference was designated as a "Patients included" meeting: https://bit.ly/3LmbH19

Our brand-new dedicated research site in Frankfurt will open its doors on 12 June. It’s an understatement to say that at FutureMeds, we are excited.    “𝙁𝙞𝙧𝙨𝙩 𝙥𝙧𝙤𝙟𝙚𝙘𝙩𝙨 𝙨𝙩𝙖𝙧𝙩𝙞𝙣𝙜 𝙨𝙤𝙤𝙣 𝙖𝙛𝙩𝙚𝙧 𝙩𝙝𝙚 𝙤𝙛𝙛𝙞𝙘𝙞𝙖𝙡 𝙤𝙥𝙚𝙣𝙞𝙣𝙜 𝙖𝙣𝙙 𝙘𝙤𝙣𝙛𝙚𝙧𝙚𝙣𝙘𝙚 𝙘𝙡𝙚𝙖𝙧𝙡𝙮 𝙨𝙝𝙤𝙬 𝙝𝙤𝙬 𝙪𝙧𝙜𝙚𝙣𝙩𝙡𝙮 𝙬𝙚 𝙣𝙚𝙚𝙙 𝙙𝙚𝙙𝙞𝙘𝙖𝙩𝙚𝙙 𝙨𝙩𝙪𝙙𝙮 𝙨𝙞𝙩𝙚𝙨 𝙞𝙣 𝙂𝙚𝙧𝙢𝙖𝙣𝙮. 𝘼 𝙡𝙖𝙧𝙜𝙚 𝙥𝙚𝙧𝙘𝙚𝙣𝙩𝙖𝙜𝙚 𝙤𝙛 𝙥𝙝𝙮𝙨𝙞𝙘𝙞𝙖𝙣𝙨 𝙖𝙣𝙙 𝙣𝙪𝙧𝙨𝙚𝙨 𝙞𝙣 𝙂𝙚𝙧𝙢𝙖𝙣𝙮 𝙖𝙧𝙚 𝙣𝙚𝙖𝙧𝙞𝙣𝙜 𝙧𝙚𝙩𝙞𝙧𝙚𝙢𝙚𝙣𝙩, 𝙖𝙣𝙙 𝙩𝙝𝙞𝙨 𝙬𝙞𝙡𝙡 𝙝𝙖𝙫𝙚 𝙖𝙣 𝙞𝙢𝙥𝙖𝙘𝙩 𝙤𝙣 𝙥𝙖𝙩𝙞𝙚𝙣𝙩 𝙘𝙖𝙧𝙚 𝙖𝙣𝙙 𝙘𝙡𝙞𝙣𝙞𝙘𝙖𝙡 𝙩𝙧𝙞𝙖𝙡 𝙘𝙖𝙥𝙖𝙘𝙞𝙩𝙮 𝙖𝙘𝙧𝙤𝙨𝙨 𝙩𝙝𝙚 𝙘𝙤𝙪𝙣𝙩𝙧𝙮,” commented Ninon Armbrust, Head of Sites at FutureMeds Germany Why Frankfurt?   + Rich tapestry of academic, industrial, and regulatory presence in life sciences  + Diverse population with 180 nationalities living in the metro area  + Good connections, convenient patient access    “𝘽𝙪𝙞𝙡𝙙𝙞𝙣𝙜 𝙤𝙣 𝙤𝙪𝙧 𝘽𝙚𝙧𝙡𝙞𝙣’𝙨 𝙨𝙞𝙩𝙚 𝙧𝙚𝙥𝙪𝙩𝙖𝙩𝙞𝙤𝙣, 𝙚𝙭𝙥𝙚𝙧𝙞𝙚𝙣𝙘𝙚 𝙖𝙣𝙙 𝙤𝙪𝙩𝙨𝙩𝙖𝙣𝙙𝙞𝙣𝙜 𝙨𝙩𝙖𝙣𝙙𝙖𝙧𝙙 𝙤𝙛 𝙦𝙪𝙖𝙡𝙞𝙩𝙮, 𝙬𝙞𝙩𝙝 𝙤𝙪𝙧 𝙁𝙧𝙖𝙣𝙠𝙛𝙪𝙧𝙩 𝙡𝙤𝙘𝙖𝙩𝙞𝙤𝙣, 𝙬𝙚 𝙖𝙞𝙢 𝙩𝙤 𝙝𝙚𝙡𝙥 𝙤𝙫𝙚𝙧𝙘𝙤𝙢𝙚 𝙨𝙤𝙢𝙚 𝙤𝙛 𝙩𝙝𝙚 𝙥𝙧𝙚𝙨𝙨𝙞𝙣𝙜 𝙩𝙧𝙞𝙖𝙡 𝙘𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨,” added Ninon.    To mark the opening, our German team is organising an exclusive conference to explore (amongst other topics) + the present and future of clinical trials in Germany  + the vital role of dedicated research sites  + how innovative solutions and DCT can alleviate constraints Save the date: https://lnkd.in/eu6Cz8-E #ClinicalTrials #ClinicalResearch

IP and Contracts- Creating value NOT Chaos- The title of my workshop at the Medilink Midlands Innovation Day on October 3rd delivered in 30 minutes...So expect some fast talking! But seriously, this will be a top tips session covering the most common issues and pitfalls we see and how to avoid/mitigate them. See you there I hope!

Great to see the Innovation Ecosystem Programme report published - and featured in the Financial Times: https://orlo.uk/Xk1IP - showing the huge potential for innovation to transform care through greater alignment of the NHS with industry and life sciences